Source:http://linkedlifedata.com/resource/pubmed/id/16282747
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2005-11-11
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1540-9740
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
273-4
|
pubmed:meshHeading |
pubmed-meshheading:16282747-History, 18th Century,
pubmed-meshheading:16282747-History, 20th Century,
pubmed-meshheading:16282747-History of Medicine,
pubmed-meshheading:16282747-Humans,
pubmed-meshheading:16282747-Porphyria Cutanea Tarda,
pubmed-meshheading:16282747-Thalidomide,
pubmed-meshheading:16282747-X-Rays
|
pubmed:articleTitle |
Why a historical approach offers clinical benefits.
|
pubmed:affiliation |
charlessteffen@cox.net
|
pubmed:publicationType |
Journal Article,
Comment,
Historical Article
|